Biomea Fusion is trading 5.7% lower at $0.57, with no specific catalyst confirmed for the October 26 move. - No clear company-specific announcement explaining the move surfaced in the search; the latest identified company release was the October 13 BMF-650 Phase 1 results. - The broader market was higher, so available evidence does not establish a market-wide explanation.